1. Home
  2. OSIS vs LNTH Comparison

OSIS vs LNTH Comparison

Compare OSIS & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSIS
  • LNTH
  • Stock Information
  • Founded
  • OSIS 1987
  • LNTH 1956
  • Country
  • OSIS United States
  • LNTH United States
  • Employees
  • OSIS N/A
  • LNTH N/A
  • Industry
  • OSIS Industrial Machinery/Components
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • OSIS Technology
  • LNTH Health Care
  • Exchange
  • OSIS Nasdaq
  • LNTH Nasdaq
  • Market Cap
  • OSIS 3.7B
  • LNTH 3.6B
  • IPO Year
  • OSIS 1997
  • LNTH 2015
  • Fundamental
  • Price
  • OSIS $228.70
  • LNTH $58.21
  • Analyst Decision
  • OSIS Strong Buy
  • LNTH Strong Buy
  • Analyst Count
  • OSIS 6
  • LNTH 6
  • Target Price
  • OSIS $229.17
  • LNTH $105.50
  • AVG Volume (30 Days)
  • OSIS 205.1K
  • LNTH 2.5M
  • Earning Date
  • OSIS 08-21-2025
  • LNTH 08-06-2025
  • Dividend Yield
  • OSIS N/A
  • LNTH N/A
  • EPS Growth
  • OSIS 18.02
  • LNTH N/A
  • EPS
  • OSIS 8.71
  • LNTH 3.77
  • Revenue
  • OSIS $1,713,166,000.00
  • LNTH $1,520,653,000.00
  • Revenue This Year
  • OSIS $6.70
  • LNTH $4.57
  • Revenue Next Year
  • OSIS $5.42
  • LNTH $9.41
  • P/E Ratio
  • OSIS $26.26
  • LNTH $15.42
  • Revenue Growth
  • OSIS 11.33
  • LNTH 5.75
  • 52 Week Low
  • OSIS $129.84
  • LNTH $47.25
  • 52 Week High
  • OSIS $241.64
  • LNTH $118.21
  • Technical
  • Relative Strength Index (RSI)
  • OSIS 53.42
  • LNTH 40.12
  • Support Level
  • OSIS $204.00
  • LNTH $55.00
  • Resistance Level
  • OSIS $236.58
  • LNTH $56.16
  • Average True Range (ATR)
  • OSIS 7.34
  • LNTH 2.52
  • MACD
  • OSIS -0.44
  • LNTH 0.57
  • Stochastic Oscillator
  • OSIS 70.31
  • LNTH 41.41

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. Majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East, and Africa, and the Asia Pacific regions.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: